AJMC Staff

Senate and House Democrats again attempt to expand fertility treatments for veterans and active-duty personnel; CDC expects high hospitalization numbers due to “tripledemic” of COVID-19, respiratory syncytial virus, and the flu; a study found that MDMA, also known as ecstasy, can reduce posttraumatic stress disorder (PTSD) symptoms.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

Millions are invested in researchers for the Cancer Moonshot initiative; some providers are charging patients for communicating online; health insurance coverage increased for half of states.

Legal actions aim to ensure abortions can be provided in emergencies; cold medication ingredient phenylephrine found to be ineffective; American nursing homes are scoring low on care quality.

FDA approves updated COVID-19 booster vaccines; low donor turnout and climate disasters result in a national blood shortage; minority patients discouraged by lack of doctor diversity.

While some types of lung cancer have targeted therapies, there remains a need for identification of biomarkers to predict treatment response in small cell lung cancer (SCLC).

While patients with other diseases have benefitted from the use of biomarkers, the lack of a biomarker in small cell lung cancer remains a disappointment, said Tom Stinchcombe, MD, medical oncologist, Duke Cancer Institute.

Navigating mask mandates and vaccine recommendations; Biden administration wants employers to have naloxone on hand; NIH nominee to receive a confirmation hearing.

Workers and employees are expected to see a growth of 6.5% or higher in health plan costs in 2024; a federal report accuses New Jersey facilities of failing to protect veterans during COVID-19; decreasing numbers of primary care physicians (PCPs) are causing alarming reductions in access.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

An uptick in laxative use causes shortage; ketamine can help suicidal thoughts but can be hard to access; new data suggest that abortions increased in most states in 2023.

The CDC reports an increase in respiratory syncytial virus (RSV) cases among young children and babies; the deadline looms for reauthorizing the United States’ global AIDS program as it has become a topic within the abortion debate; an eye-tracking device may help to diagnose autism spectrum disorder earlier.

Rising temperatures demand action against heat-related illnesses; school superintendents face complex decisions as COVID-19 cases rise; national staffing standards for nursing homes present challenges.

CMS announces assistance for Hurricane Idalia emergency; deaths from drug overdoses due to counterfeit drugs reach historic high; customers are paying thousands of dollars out-of-pocket for off-label weight loss drugs.

The demand for mental health staff in schools outweighs the supply; the FDA sends letters to 3 formula manufacturers for federal violations; Narcan is coming to stores around the country.

Artificial intelligence (AI) tool NarxCare influences and limits painkiller prescriptions to help fight the US opioid epidemic; legislators in states with strict abortion bans are directing residents to pregnancy resource centers; air pollution is reportedly more dangerous to the average person’s health than smoking or alcohol.

Telemedicine abortions in Iowa have increased in recent months; 2 new laws restrict access to gender-affirming health care and school sports in Missouri; the end of COVID-19 safety nets means many children have lost Medicaid coverage.

COVID-19 hospital visits by adolescents nearly doubled; government to release list of drugs Medicare will be able to negotiate prices for; Rite Aid gears up for bankruptcy while facing lawsuits over alleged opioid involvement.

CDC outlines new procedures for sepsis response; mask mandates resurface during COVID-19 increase; a recent study shows that technology can help support public health programs.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

The Biden administration is expected to unveil the first 10 drugs identified for drug price negotiations Tuesday; American nursing homes are disappearing; gender-affirming surgeries tripled in the United States between 2016-2019.

Patients and physicians are publicly shaming insurance companies on social media for the troublesome prior authorization process; HHS has awarded $1.4 billion in grants for the creation of new technologies and tools to prevent COVID-19 infection; Novo Nordisk has increased lobbying efforts to allow Medicare coverage of weight loss drugs.

Novavax’s COVID-19 vaccine shows immunity against the Eris subvariant; infants with excessive screen time are at higher risk of developmental delays; a near-total abortion ban is expected to go into effect in Indiana within days.

About 17 million middle-class Americans have unpaid medical bills; more than 1 in 5 patients hospitalized with COVID-19 developed high blood pressure; work requirements for Supplemental Nutrition Assistance Program (SNAP) benefits to begin in September.

A 75-year-old foundation updates its name to reflect a more comprehensive mission.

The targeted therapy already has indications in acute myeloid leukemia.

A new CMS proposal would authorize Medicare payments to cover family caregiver training; US list prices for popular weight loss drugs are higher than those of other wealthy nations; Midwestern cities declare themselves sanctuary cities despite anti-LGBT state laws passed.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

Trends show rising rates of cancers among young adults; The Physicians Foundation launches program to address social determinants of health; Blue Shield California drops CVS health